Target intelligence / Profile preview

Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 pseudogene 25 (MTND6P25)

Target
MTND6P25
Molecular classification
Other, Pseudogene
01

Overview

MTND6P25, or "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 pseudogene 25," is a **pseudogene** related to the MT-ND6 gene, which provides instructions for producing a subunit (ND6) of the mitochondrial respiratory chain complex I[1][2]. However, as a pseudogene, MTND6P25 does not encode a functional protein and is **not considered a therapeutic target, receptor, enzyme, or transporter**. Information about this pseudogene's structure, biological function, or role in disease is not available in the scientific literature. The functional MT-ND6 gene is crucial for mitochondrial electron transport and ATP synthesis, with pathogenic mutations implicated in mitochondrial diseases such as Leber hereditary optic neuropathy and Leigh disease[1][2][3][4]. In contrast, pseudogenes like MTND6P25 typically do not contribute to biological pathways or serve as drug targets. **Key points supporting classification as "incorrect/irrelevant target":** - "Pseudogene" indicates it does not code for a functional protein. - No evidence for use as a therapeutic target, biomarker, or drug interaction[2][3]. - All known functional data relate to the protein-coding MT-ND6, *not* its pseudogenes[1][2][3]. In summary, **MTND6P25** is a non-coding pseudogene, not a relevant drug or research target, and should not be confused with the functional mitochondrial MT-ND6 gene.

Other names
MT-ND6 pseudogene 25MTND6P25mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 pseudogene 25

Beyond the preview

Go deeper on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 pseudogene 25 (MTND6P25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 pseudogene 25 (MTND6P25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call